Glaxo Group Limited

Active00305979 Private limited company
Incorporated
14 October 1935 (91 years)
Industry
Activities of head offices (70100)
Directors
Owned by
Accounts type
Full
Region
East of England
Address
Gsk Medicines Research Centre
Gunnels Wood Road
Stevenage
SG1 2NY

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
14 April 2027
Last conf. stmt
31 March 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 4 active

Officer details are public data from the Companies House register.

Director · Appointed 1 October 2015
Also at Glaxosmithkline Intellectual Property Holdings Limited, Glaxosmithkline Intellectual Property Limited, Smithkline Beecham Legacy H Limited · more companies
British
Born November 1967
Corporate Director · Appointed 5 March 2002
Also at Glaxosmithkline Finance PLC, Glaxosmithkline Intellectual Property Management Limited, GSK Finance (No 2) Limited · more companies
Secretary · Appointed 6 June 2001
Also at Glaxosmithkline Services Unlimited, GSK PLC, Beecham Group PLC · more companies
British
Corporate Director · Appointed 31 January 2001
Also at British Pharma Group Limited, Glaxosmithkline Services Unlimited, Beecham Group PLC · more companies
Officer history (28 former)
19 July 2025
Resigned Brown, Julie Belita as Director
1 May 2023
Appointed Brown, Julie Belita as Director
1 May 2023
Resigned Mackay, Iain James as Director
1 May 2019
Resigned Dingemans, Simon Paul as Director
1 May 2019
Appointed Mackay, Iain James as Director
1 March 2016
Resigned Blackburn, Paul Frederick as Director
1 October 2015
Appointed Walker, Adam as Director
1 April 2011
Appointed Dingemans, Simon Paul as Director
31 March 2011
Resigned Heslop, Julian Spenser as Director
28 February 2011
Resigned Bicknell, Simon Michael as Secretary
5 March 2007
Resigned Stephens, Richard James as Secretary
21 July 2005
Appointed Blackburn, Paul Frederick as Director
31 March 2005
Resigned Coombe, John David as Director
21 July 2003
Appointed Stephens, Richard James as Secretary
20 May 2002
Resigned Sykes, Richard Brook, Sir as Director
5 March 2002
Appointed The Wellcome Foundation Limited as Corporate Director
6 June 2001
Appointed Whyte, Victoria Anne as Secretary
31 January 2001
Appointed Bicknell, Simon Michael as Secretary
31 January 2001
Appointed Heslop, Julian Spenser as Director
31 January 2001
Appointed Edinburgh Pharmaceutical Industries Limited as Corporate Director
31 January 2001
Resigned Cowden, Stephen John as Secretary
31 January 2001
Resigned Cochrane, James Michael Thomas as Director
31 December 2000
Resigned Strachan, Jeremy Alan Watkin as Director
7 November 1997
Resigned Lance, Sean Patrick as Director
1 February 1996
Appointed Cowden, Stephen John as Secretary
1 February 1996
Resigned Morris, Nicholas Guy Usher as Secretary
6 September 1995
Appointed Cochrane, James Michael Thomas as Director
11 October 1994
Appointed Lance, Sean Patrick as Director
11 October 1994
Resigned Girolami, Paul, Sir as Director
12 May 1993
Resigned Hignett, John Mulock as Director
12 May 1993
Appointed Sykes, Richard Brook, Sir as Director
12 May 1993
Appointed Girolami, Paul, Sir as Director
11 May 1993
Resigned Mario, Ernest as Director
2 February 1993
Resigned Humer, Franz Bernhard as Director
1 February 1993
Appointed Hignett, John Mulock as Director
1 February 1993
Appointed Morris, Nicholas Guy Usher as Secretary
31 January 1993
Resigned Challoner, Stanley Clive as Director
31 January 1993
Resigned Eaves, Terence, Doctor as Director
31 January 1993
Resigned Pinto, Francis Joseph, Dr as Director
31 January 1993
Resigned Potter, Geoffrey as Director
31 January 1993
Resigned Williams, Paul Martin as Director
31 January 1993
Resigned Youmans, James Clifford as Director
31 January 1993
Resigned Blaker, Graham Joseph, Dr as Director
31 January 1993
31 January 1993
Resigned Adam, Christopher as Director
31 January 1993
Resigned Hyde, Jonathan Laurence Patrick as Secretary

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 242686

Holdings 17

Companies where Glaxo Group Limited is registered as a person with significant control

Active
Owns 75–100% of shares
Active
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
Active
Active
Active
In liquidation
Active
Active
Active
Owns 75–100% of shares
Active
Owns 75–100% of shares
In liquidation
Owns 75–100% of shares
Active
Owns 75–100% of shares
Dissolved
Holds 75–100% of voting rights
Active

Group structure 22 shown

Ownership group derived from the Companies House PSC register

GSK PLC
British Pharma Group Limited Holds 25–50% of voting rights
Glaxosmithkline Holdings (One) Limited Owns 75–100% of shares
Glaxosmithkline Holdings Limited Owns 75–100% of shares
Glaxosmithkline Finance PLC Owns 75–100% of shares
Glaxo Group Limited This company Owns 75–100% of shares
Glaxosmithkline Ihc Limited Owns 75–100% of shares
GSK Finance (No 2) Limited Owns 75–100% of shares
Setfirst Limited Owns 75–100% of shares
Smithkline Beecham Limited Owns 75–100% of shares
Wellcome Limited Owns 75–100% of shares
Glaxosmithkline Mercury Limited Owns 75–100% of shares
Viiv Healthcare Limited Owns 75–100% of shares
Viiv Healthcare Finance 2 Limited Owns 75–100% of shares
Viiv Healthcare Overseas Limited Owns 75–100% of shares
Viiv Healthcare Trading Services UK Limited Owns 75–100% of shares
Viiv Healthcare UK (No.4) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.5) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.6) Limited Owns 75–100% of shares
Viiv Healthcare UK (No.7) Limited Owns 75–100% of shares
Viiv Healthcare UK Limited Owns 75–100% of shares
Glaxosmithkline Services Unlimited Owns 75–100% of shares

Filings 268

DateDescriptionMade Up ToPagesPDF
10 August 2026Full accounts31 December 2025
31 March 2026Confirmation statement with no updates31 March 2026
1 August 2025Full accounts31 December 2024
30 July 2025Confirmation statement with no updates30 July 2025
28 July 2025Termination of appointment of a director
Show all 268 filings

Some other companies at this address

GSK Equity Investments No2 Limited
Domantis Limited
Galvani Bioelectronics Limited
Glaxo Wellcome UK Limited
Glaxosmithkline Intellectual Property (No.2) Limited
Glaxosmithkline Intellectual Property (No.3) Limited

Other companies in this industry

London
London
London
London
Birmingham
Reading

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?